Perfusia biosciences

Perfusia biosciences is a biotech startup developing next generation in vitro disease models for pharmaceutical drug testing. Perfusia Biosciences aims to redefine the gold standard for preclinical models of human disease. A major and costly point of failure in the drug development pipeline is the inability of current preclinical models to accurately portray human physiology. As a result, many drugs tested in monolayer cell culture or animal models fail in clinical trials due to unforeseen complexities in human patients.